BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2837213)

  • 1. A splicing defect due to an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease.
    Ohno K; Suzuki K
    Biochem Biophys Res Commun; 1988 May; 153(1):463-9. PubMed ID: 2837213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple abnormal beta-hexosaminidase alpha chain mRNAs in a compound-heterozygous Ashkenazi Jewish patient with Tay-Sachs disease.
    Ohno K; Suzuki K
    J Biol Chem; 1988 Dec; 263(34):18563-7. PubMed ID: 2973464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease.
    Akli S; Chelly J; Mezard C; Gandy S; Kahn A; Poenaru L
    J Biol Chem; 1990 May; 265(13):7324-30. PubMed ID: 2139660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients.
    Akli S; Chomel JC; Lacorte JM; Bachner L; Kahn A; Poenaru L
    Hum Mol Genet; 1993 Jan; 2(1):61-7. PubMed ID: 8490625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase.
    Myerowitz R; Costigan FC
    J Biol Chem; 1988 Dec; 263(35):18587-9. PubMed ID: 2848800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal transcription of the beta-hexosaminidase alpha-chain gene in the Ashkenazi Tay-Sachs mutation.
    Paw BH; Neufeld EF
    J Biol Chem; 1988 Feb; 263(6):3012-5. PubMed ID: 2449434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada.
    Hechtman P; Boulay B; De Braekeleer M; Andermann E; Melançon S; Larochelle J; Prevost C; Kaplan F
    Hum Genet; 1992 Dec; 90(4):402-6. PubMed ID: 1483696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tay-Sachs disease: intron 7 splice junction mutation in two Portuguese patients.
    Ribeiro MG; Pinto R; Miranda MC; Suzuki K
    Biochim Biophys Acta; 1995 Jan; 1270(1):44-51. PubMed ID: 7827134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An A-to-G mutation at the +3 position of intron 8 of the HEXA gene is associated with exon 8 skipping and Tay-Sachs disease.
    Richard MM; Erenberg G; Triggs-Raine BL
    Biochem Mol Med; 1995 Jun; 55(1):74-6. PubMed ID: 7551830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles.
    Landels EC; Green PM; Ellis IH; Fensom AH; Bobrow M
    J Med Genet; 1992 Aug; 29(8):563-7. PubMed ID: 1387685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group.
    Myerowitz R
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3955-9. PubMed ID: 3375249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The major mutation among Japanese patients with infantile Tay-Sachs disease: a G-to-T transversion at the acceptor site of intron 5 of the beta-hexosaminidase alpha gene.
    Tanaka A; Sakuraba H; Isshiki G; Suzuki K
    Biochem Biophys Res Commun; 1993 Apr; 192(2):539-46. PubMed ID: 8484765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in the invariant AG of the acceptor splice site of intron 4 of the beta-hexosaminidase alpha-subunit gene in two unrelated American black GM2-gangliosidosis (Tay-Sachs disease) patients.
    Mules EH; Dowling CE; Petersen MB; Kazazian HH; Thomas GH
    Am J Hum Genet; 1991 Jun; 48(6):1181-5. PubMed ID: 1827945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase.
    Navon R; Proia RL
    Am J Hum Genet; 1991 Feb; 48(2):412-9. PubMed ID: 1825014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chronic GM2 gangliosidosis variant with a HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts.
    Fernandes MJ; Hechtman P; Boulay B; Kaplan F
    Eur J Hum Genet; 1997; 5(3):129-36. PubMed ID: 9272736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients.
    Tanaka A; Ohno K; Sandhoff K; Maire I; Kolodny EH; Brown A; Suzuki K
    Am J Hum Genet; 1990 Feb; 46(2):329-39. PubMed ID: 2137287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the beta-hexosaminidase alpha subunit gene with the four-base insertion of infantile Jewish Tay-Sachs disease.
    Nishimoto J; Tanaka A; Nanba E; Suzuki K
    J Biol Chem; 1991 Aug; 266(22):14306-9. PubMed ID: 1830584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new point mutation in the beta-hexosaminidase alpha subunit gene responsible for infantile Tay-Sachs disease in a non-Jewish Caucasian patient (a Kpn mutant).
    Tanaka A; Punnett HH; Suzuki K
    Am J Hum Genet; 1990 Sep; 47(3):568-74. PubMed ID: 2144098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of the Tay-Sachs disease splice and insertion mutations in the UK Ashkenazi Jewish population.
    Landels EC; Ellis IH; Fensom AH; Green PM; Bobrow M
    J Med Genet; 1991 Mar; 28(3):177-80. PubMed ID: 1828838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program.
    Paw BH; Tieu PT; Kaback MM; Lim J; Neufeld EF
    Am J Hum Genet; 1990 Oct; 47(4):698-705. PubMed ID: 2220809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.